From Obesity to Inflammation: Common Pathways and New Opportunities in HF

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:

• Grant Support/Research Contract - Abbvie
• Consultant Fee/Honoraria/Speaker's Bureau - Boehringer Ingelheim; Actavis; Medtronic; 89bio; Altimmune; Alnylam; Ardelyx; Attralus; Biopeutics; Caladrius; Casana; CSL Behring; Imara; Lilly; Moderna; Novartis; Pharmacosmos; Reata; Regeneron; Salamandra